ACHC PCAB Compounding Pharmacy Accreditation — Frequently Asked Questions
Answers to 12 common questions about PCAB accreditation, USP standards, inspection process, and common deficiencies for compounding pharmacies.
What is ACHC PCAB Compounding Pharmacy Accreditation?
ACHC PCAB Compounding Pharmacy Accreditation is delivered through ACHC's partnership with the Pharmacy Compounding Accreditation Board (PCAB). It establishes and verifies quality and safety standards for sterile and non-sterile compounding pharmacies, incorporating USP <797>, <795>, and <800> requirements. PCAB has become the gold standard for compounding pharmacy quality credentials.
What is the relationship between ACHC and PCAB?
PCAB partnered with ACHC to deliver and administer the PCAB accreditation program. ACHC manages the accreditation process, inspections, and standards maintenance. Pharmacies apply through ACHC and receive PCAB accreditation — the quality credential recognized by payers, prescribers, and hospital systems.
What USP standards does PCAB accreditation incorporate?
Incorporates USP <797> (Sterile Preparations), USP <795> (Nonsterile Preparations), and USP <800> (Hazardous Drugs). Pharmacies must demonstrate compliance with applicable chapters for their compounding categories. The 2023 revised USP <797> introduced significant changes affecting most sterile compounding programs.
Is PCAB accreditation required for compounding pharmacies?
Voluntary — not mandated by FDA or state boards. However, many PBMs, managed care organizations, and hospital pharmacy purchasing departments require PCAB accreditation for vendor approval. Non-accredited pharmacies may face PBM network exclusion, hospital formulary rejection, or reimbursement barriers.
What are the major domains evaluated in a PCAB inspection?
Evaluates: Organizational Management, Personnel Qualifications and Training, Facilities and Equipment (clean room classification, HVAC, equipment qualification), Sterile Compounding (USP <797> environmental monitoring, media fill, glove fingertip testing), Non-Sterile Compounding (USP <795>), Hazardous Drug Handling (USP <800>), SOP document control, Quality Control and Testing, and Patient/Prescriber Safety.
What changed in the 2023 revised USP <797>?
Key changes: shortened BUDs for Category 1 CSPs not supported by sterility testing; new environmental monitoring frequency requirements by ISO classification; mandatory sterility testing for Category 2 CSPs; revised personnel competency requirements including glove fingertip testing; and new contamination risk evaluation requirements. Pharmacies not updated to the 2023 revision will receive deficiencies in PCAB inspections.
What are the most common deficiencies in PCAB inspections?
Common deficiencies: environmental monitoring gaps (insufficient frequency, failure to investigate action level exceedances), beyond-use dating violations, personnel competency documentation failures, SOP deficiencies (outdated or inadequately controlled procedures), equipment calibration gaps, hazardous drug handling deficiencies, and quality control testing failures.
What is the difference between a 503A pharmacy and a 503B outsourcing facility?
503A regulates traditional compounders dispensing pursuant to patient-specific prescriptions. 503B regulates outsourcing facilities that may compound without patient-specific prescriptions for healthcare settings, under FDA oversight. Both can pursue PCAB accreditation. 503B facilities operate under more intensive FDA inspection and cGMP expectations.
How often does PCAB conduct compounding pharmacy inspections?
PCAB accreditation is valid for two years with biennial on-site inspections, plus complaint-based inspections and follow-up validation visits for significant deficiencies.
What environmental monitoring is required for sterile compounding?
Programs must include viable air sampling (active and passive), surface sampling (contact plates and swabs), non-viable particle counting, and temperature/humidity/pressure differential monitoring. Sampling locations, frequencies, action limits, alert limits, and investigation procedures must all be documented per current USP <797> and ISO classification requirements.
How long does PCAB accreditation take?
Plan 9 to 15 months depending on USP compliance maturity, SOP documentation completeness, environmental monitoring program status, and personnel competency records. Pharmacies implementing the 2023 revised USP <797> requirements should plan for the longer end of the range.
How does IHS support PCAB accreditation?
IHS provides gap analysis against current PCAB/USP standards, SOP development, environmental monitoring program design, personnel competency architecture, beyond-use dating review, mock inspection preparation, and Plan of Correction development. Led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC.
Ready to Pursue PCAB Compounding Pharmacy Accreditation?
Schedule a free discovery session with IHS to discuss your pharmacy's readiness and next steps.
Schedule a Free Discovery Session